778208 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial |
2021-12-01 |
10.1136/jitc-2021-003645 |
Moreno Victor, Barretina-Ginesta Maria-Pilar, García-Donas Jesús, Jayson Gordon C, Roxburgh Patricia, Vázquez Raúl Márquez, Michael Agnieszka, Antón-Torres Antonio, Brown Richard, Krige David, Champion Brian, McNeish Iain |
778207 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz et al |
2021-12-01 |
10.1136/jitc-2021-003751 |
Mora Jaume, Chantada Guillermo L |
778206 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Immunization with short peptide particles reveals a functional CD8+ T-cell neoepitope in a murine renal carcinoma model |
2021-12-01 |
10.1136/jitc-2021-003101 |
He Xuedan, Zhou Shiqi, Dolan Melissa, Shi Yuhao, Wang Jianxin, Quinn Breandan, Jahagirdar Dushyant, Huang Wei-Chiao, Tsuji Moriya, Pili Roberto, Ito Fumito, Ortega Joaquin, Abrams Scott I, Ebos John M L, Lovell Jonathan F |
778205 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer |
2021-12-01 |
10.1136/jitc-2021-002597corr1 |
|
778204 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Factors associated with the clinical outcome of patients with relapsed/refractory CD19+ acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy |
2021-12-01 |
10.1136/jitc-2021-003644 |
Ortiz-Maldonado Valentín, Rives Susana, Español-Rego Marta, Alonso-Saladrigues Anna, Montoro Mercedes, Magnano Laura, Giné Eva, Pascal Mariona, Díaz-Beyá Marina, Castella Maria, Català Albert, Faura Anna, Rodríguez-Lobato Luis Gerardo, Oliver-Caldes Aina, Martínez-Roca Alexandra, Rovira Montserrat, González-Navarro E Azucena, Ortega Juan Ramón, Cid Joan, Lozano Miquel, Garcia-Rey Enric, Fernández Sara, Castro Pedro, Jordan Iolanda, Villamor Neus, Aymerich Marta, Torrebadell Montserrat, Deyà Àngela, Fernández de Larrea Carlos, Benitez-Ribas Daniel, Trias Esteve, Varea Sara, Calvo Gonzalo, Esteve Jordi, Urbano-Ispizua Alvaro, Juan Manel, Delgado Julio |
778203 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors |
2021-12-01 |
10.1136/jitc-2021-002890corr1 |
|
778202 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer |
2021-12-01 |
10.1136/jitc-2021-002780 |
Kim Chang Gon, Kim Gamin, Kim Kyung Hwan, Park Seyeon, Shin Sunhye, Yeo Dahee, Shim Hyo Sup, Yoon Hong In, Park Seong Yong, Ha Sang-Jun, Kim Hye Ryun |
778201 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Combinatorial immunotherapy induces tumor-infiltrating CD8+ T cells with distinct functional, migratory, and stem-like properties |
2021-12-01 |
10.1136/jitc-2021-003614 |
Van Braeckel-Budimir Natalija, Dolina Joseph Samuel, Wei Jie, Wang Xiao, Chen Shih-Hsun, Santiago Pamela, Tu Guanghuan, Micci Luca, Al-Khami Amir A, Pfister Sophia, Ram Sripad, Sundar Purnima, Thomas Graham, Long Hua, Yang Wenjing, Potluri Shobha, Salek-Ardakani Shahram |
778200 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers |
2021-12-01 |
10.1136/jitc-2021-003414 |
Kim Jung Ho, Seo Mi-Kyoung, Lee Ji Ae, Yoo Seung-Yeon, Oh Hyeon Jeong, Kang Hyundeok, Cho Nam-Yun, Bae Jeong Mo, Kang Gyeong Hoon, Kim Sangwoo |
778199 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Immunogenic ferroptosis and where to find it? |
2021-12-01 |
10.1136/jitc-2021-003430 |
Demuynck Robin, Efimova Iuliia, Naessens Faye, Krysko Dmitri V |